Larsson O M, Falch E, Krogsgaard-Larsen P, Schousboe A
Department of Biology MN, Royal Danish School of Pharmacy, Copenhagen, Denmark.
J Neurochem. 1988 Mar;50(3):818-23. doi: 10.1111/j.1471-4159.1988.tb02986.x.
The effects of N-(4,4-diphenyl-3-butenyl) derivatives of nipecotic acid (SKF-89976-A and SKF-100844-A) and guvacine (SKF-100330-A) on neuronal and astroglial gamma-aminobutyric acid (GABA) uptake were investigated. In addition, the uptake of SKF-89976-A was studied using the tritiated compound. All of the compounds were found to be competitive inhibitors of GABA uptake irrespective of the cell type, with Ki values similar to or lower than those of the parent amino acids. Moreover, none of the compounds exhibited selectivity with regard to inhibition of neuronal and glial GABA uptake. In spite of the competitive nature of SKF-89976-A, the compound was not transported by the GABA carriers in the two cell types, because no saturable uptake could be demonstrated.
研究了哌啶酸的N-(4,4-二苯基-3-丁烯基)衍生物(SKF-89976-A和SKF-100844-A)以及胍可亚胺(SKF-100330-A)对神经元和星形胶质细胞γ-氨基丁酸(GABA)摄取的影响。此外,使用氚标记化合物研究了SKF-89976-A的摄取。发现所有这些化合物都是GABA摄取的竞争性抑制剂,与细胞类型无关,其抑制常数(Ki)值与母体氨基酸相似或更低。此外,这些化合物在抑制神经元和胶质细胞GABA摄取方面均未表现出选择性。尽管SKF-89976-A具有竞争性,但该化合物在两种细胞类型中均未被GABA载体转运,因为未表现出可饱和摄取。